In this study, we investigated the affinity of anti-GM1 IgG antibodies
as well as their IgG subclass distribution in a series of 38 patients
with Guillain-Barre syndrome. In 7 sera elevated titres of IgG anti-G
M1 antibodies could be detected. With respect to affinity there were t
wo distinct groups of anti-GM1 antibodies: one group was of high affin
ity and did not cross-react with other glycolipids; the other group wa
s of low affinity and cross-reacted with asialo-GM1. IgG1 was the pred
ominant and almost exclusive subclass of high affinity anti-GM1 antibo
dies. Axonal degeneration occurred significantly more frequently in pa
tients with high affinity anti-GM1 antibodies than in patients without
anti-GM1 antibodies or in patients with low affinity anti-GM1 antibod
ies. The presence of anti-Campylobacter jejuni antibodies was not asso
ciated with a specific electrophysiological pattern. The prognosis was
not dependent on the detection of any of the antibodies, whereas axon
al loss and ventilation were associated with a poor prognosis.